Hibernating myocardium: Pathophysiology, diagnosis, and treatment

Canadian Journal of Physiology and Pharmacology

Volumn 87, Issue 4, 2009, Pages 252-265

  Slezak, Jan ^a,b   Tribulova, Narcis ^b   Okruhlicova, Ludmila ^b   Dhingra, Rimpy ^a   Bajaj, Anju ^a   Freed, Darren ^a   Singal, Pawan ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b INSTITUTE OF CHEMISTRY   (Slovakia)

Author keywords

Growth factors; Ischemic injury; Myocardial heterogeneity; Neovascularization

Indexed keywords

ADENOVIRUS VECTOR; ANGIOPOIETIN 1; CALCIUM ION; CONNEXIN 43; ERYTHROPOIETIN; ESTROGEN; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR 5; GLUCOSE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LO FIBROBLAST GROWTH FACTOR 2; OMEGA 3 FATTY ACID; POTASSIUM; RESVERATROL; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE 2A; SOMATOMEDIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; AUTOLOGOUS STEM CELL TRANSPLANTATION; CORONARY ARTERY BYPASS SURGERY; DIAGNOSTIC ACCURACY; HEART INFARCTION; HEART MUSCLE BLOOD FLOW; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART MUSCLE REVASCULARIZATION; HEART PROTECTION; HUMAN; ISCHEMIC HEART DISEASE; LASER SURGERY; MYOCARDIAL HIBERNATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RADIODIAGNOSIS; REVIEW; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANIMALS; CALCIUM; HUMANS; MYOCARDIAL STUNNING; MYOCYTES, CARDIAC; NEOVASCULARIZATION, PHYSIOLOGIC; STEM CELL TRANSPLANTATION;

EID: 65249139948     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/Y09-011     Document Type: Review

References (130)

1. Alexánderson, E., Ricalde, A., Zerón, J., Talayero, J.A., Cruz, P., Adame, G., et al. 2006. Discordant pattern, visual identification of myocardial viability with PET. Arch. Cardiol. Mex. 76: 347-354. PMID:17315610.
2. Ambrosio, G., and Tritto, I. 2001. Clinical manifestations of myo- cardial stunning. Coron. Artery Dis. 12: 357-361. doi:10.1097/ 00019501-200108000-00004. PMID:11491200.
3. Ambrosio, G., Betocchi, S., Pace, L., Losi, M.A., Perrone-Filardi, P., Soricelli, A., et al. 1996. Prolonged impairment of regional contractile function after resolution of exercise-induced angina: evidence of myocardial stunning in patients with coronary artery disease. Circulation, 94: 2455-2464. PMID:8921788.
4. Angelini, A., Maiolino, G., La Canna, G., Ceconi, C., Calabrese, F., Pettenazzo, E., et al. 2007. Relevance of apoptosis in influencing recovery of hibernating myocardium. Eur. J. Heart Fail. 9: 377-383. doi:10.1016/j.ejheart.2006.09.012. PMID:17127093.
5. Asanuma, H., Minamino, T., Ogai, A., Kim, J., Asakura, M., Ko- mamura, K., et al. 2006. Blockade of histamine H2 receptors protects the heart against ischemia and reperfusion injury in dogs. J. Mol. Cell. Cardiol. 40: 666-674. doi:10.1016/j.yjmcc. 2006.02.001. PMID:16603184.
6. Atluri, P., Panlilio, C.M., Liao, G.P., Suarez, E.E., McCormick, R.C., Hiesinger, W., et al. 2008. Transmyocardial revascularization to enhance myocardial vasculogenesis and hemodynamic function. J. Thorac. Cardiovasc. Surg. 135: 283-291. doi:10.1016/j.jtcvs.2007.09.043. PMID:18242252.
7. Beeres, S.L., Bax, J.J., Dibbets, P., Stokkel, M.P., Zeppenfeld, K., Fibbe, W.E., et al. 2006. Effect of intramyocardial injection of autologous bone marrow-derived mononuclear cells on perfu- sion, function, and viability in patients with drug-refractory chronic ischemia. J. Nucl. Med. 47: 574-580. PMID:16595489.
8. Beeres, S.L., Zeppenfeld, K., Bax, J.J., Dibbets-Schneider, P., Stok- kel, M.P., Fibbe, W.E., et al. 2007. Electrophysiological and ar- rhythmogenic effects of intramyocardial bone marrow cell injection in patients with chronic ischemic heart disease. Heart Rhythm, 4: 257-265. doi:10.1016/j.hrthm. 2006.10.033. PMID: 17341383.
9. Bhakta, S., Greco, N.J., Finney, M.R., Scheid, P.E., Hoffman, R.D., Joseph, M.E., et al. 2006. The safety of autologous intracoronary stem cell injections in a porcine model of chronic myocardial ischemia. J. Invasive Cardiol. 18: 212-218. PMID:16670448.
10. Bito, V., van der Velden, J., Claus, P., Dommke, C., Van Lommel, A., Mortelmans, L., et al. 2007. Reduced force generating capacity in myocytes from chronically ischemic, hibernating myocardium. Circ. Res. 100: 229-237. doi:10.1161/01.RES. 0000257829.07721.57. PMID:17234974.
11. Borgers, M., and Ausma, J. 1995. Structural aspects of the chronic hibernating myocardium in man. Basic Res. Cardiol. 90: 44-46. PMID:7779058.
12. Borgers, M., Thone, F., Wouters, L., Ausma, J., Shivalkar, B., and Flameng, W. 1993. Structural correlates of regional myocardial dysfunction in patients with critical coronary artery stenosis: chronic hibernation? Cardiovasc. Pathol. 2: 237-245. doi:10. 1016/1054-8807(93)90030-6.
13. Centurion, O.A. 2007. The open artery hypothesis: beneficial effects and long-term prognostic importance of patency of the in- farct- related coronary artery. Angiology, 58: 34-44. doi:10.1177/0003319706295212. PMID:17351156.
14. Chaudhuri, A., Janicke, D., Wilson, M.F., Tripathy, D., Garg, R., Bandyopadhyay, A., et al. 2004. Anti-inflammatory and profibri- nolytic effect of insulin in acute ST- segment- elevation myocardial infarction. Circulation, 109: 849-854. doi:10.1161/01.CIR. 0000116762.77804.FC. PMID:14757687.
15. Day, S.M., Westfall, M.V., and Metzger, J.M. 2007. Tuning cardiac performance in ischemic heart disease and failure by modulating myofilament function. J. Mol. Med. 85: 911-921. doi:10.1007/ s00109-007-0181-6. PMID:17396243.
16. Deindl, E., Buschmann, I., Hoefer, I.E., Podzuweit, T., Boengler, K., Vogel, S., et al. 2001. Role of ischemia and of hypoxia-in- ducible genes in arteriogenesis after femoral artery occlusion in the Rabbit. Circ. Res. 89: 779-786. doi:10.1161/hh2101.098613. PMID:11679407.
17. Depre, C., and Vatner, S.F. 2007. Cardioprotection in stunned and hibernating myocardium. Heart Fail. Rev. 12: 307-317. doi:10.1007/s10741-007-9040-3. PMID:17541819.
18. Depre, C., Tomlinson, J.E., Kudej, R.K., Gaussin, V., Thompson, E., Kim, S.J., et al. 2001. Gene program for cardiac cell survival induced by transient ischemia in conscious pigs. Proc. Natl. Acad. Sci. U.S.A. 98: 9336-9341. doi:10.1073/pnas.171297498. PMID:11481491.
19. Depre, C., Kim, S.J., John, A.S., Huang, Y., Rimoldi, O.E., Pepper, J.R., et al. 2004. Program of cell survival underlying human and experimental hibernating myocardium. Circ. Res. 95: 433-440. doi:10.1161/01.RES. 0000138301.42713.18. PMID:15242971.
20. 2+ transport in different areas of dog heart. Can. J. Physiol. Pharmacol. 58: 360-367. PMID: 6446372.
21. Dhein, S. 1998. Gap junction channels in the cardiovascular system: pharmacological and physiological modulation. Trends Pharmacol. Sci. 19: 229-241. doi:10.1016/S0165-6147(98) 01192-4. PMID:9666714.
22. Dilsizian, V. 2007. Cardiac magnetic resonance versus SPECT: Are all noninfarct myocardial regions created equal? J. Nucl. Cardiol. 14: 9-14. doi:10.1016/j.nuclcard.2006.12.143. PMID:17276300.
23. Driesen, R.B., Verheyen, F.K., Dijkstra, P., Thone, F., Cleutjens, J.P., Lenders, M.H., et al. 2007. Structural remodelling of cardi- omyocytes in the border zone of infarcted rabbit heart. Mol. Cell. Biochem. 302: 225-232. doi:10.1007/s11010-007-9445-2. PMID:17387581.
24. Eaton, P., Hearse, D.J., and Shattock, M.J. 2001. Lipid hydroperoxide modification of proteins during myocardial ischaemia. Cardi- ovasc. Res. 51: 294-303. doi:10.1016/S0008-6363(01)00303-0. PMID:11470469.
25. Egashira, K. 2003. Molecular mechanisms mediating inflammation in vascular disease: special reference to monocyte chemoattrac- tant protein-1. Hypertension, 41: 834-841. doi:10.1161/01.HYP. 0000051642.65283.36. PMID:12624005.
26. Elsasser, A., Schlepper, M., Klovekorn, W.P., Cai, W.J., Zimmer- mann, R., Müller, K.D., et al. 1997. Hibernating myocardium: an incomplete adaptation to ischemia. Circulation, 96: 2920-2931. PMID:9386158.
27. Elsasser, A., Decker, E., Kostin, S., Hein, S., Skwara, W., Miiller, K.D., et al. 2000. A self-perpetuating vicious cycle of tissue damage in human hibernating myocardium. Mol. Cell. Biochem. 213: 17-28. doi:10.1023/A:1007182617215. PMID:11129954.
28. Elsasser, A., Müller, K.D., Skwara, W., Bode, C., Kubler, W., and Vogt, A.M. 2002. Severe energy deprivation of human hibernating myocardium as possible common pathomechanism of contractile dysfunction, structural degeneration and cell death. J. Am. Coll. Cardiol. 39: 1189-1198. doi:10.1016/S0735-1097(02) 01735-7. PMID:11923045.
29. Engvall, E. 1995. Structure and function of basement membranes. Int. J. Dev. Biol. 39: 781-787. PMID:8645562. Fallavollita, J.A., and Canty, J.M., Jr. 1999. Differential 18F-2-deoxyglucose uptake in viable dysfunctional myocardium with normal resting perfusion: evidence for chronic stunning in pigs. Circulation, 99: 2798-2805. PMID:10351975.
30. Feigl, E.O. 1983. Coronary physiology. Physiol. Rev. 63: 1-205. PMID:6296890.
31. Feola, M., Biggi, A., Francini, A., Leonardi, G., Vado, A., Ribichini, F., and Uslenghi, E. 2006. Placebo or trimetazidine (99m)Tc te- trofosmin myocardial SPECT and low-dose dobutamine echocardiography in hibernating myocardium. Arch. Med. Res. 37: 117-122. doi:10.1016/j.arcmed.2005.05. 011. PMID:16314196.
32. Fischer- Rasokat, U., Beyersdorf, F., and Doenst, T. 2003. Insulin addition after ischemia improves recovery of function equal to ischemic preconditioning in rat heart. Basic Res. Cardiol. 98: 329-336. doi:10.1007/s00395-003-0414-y. PMID:12955406.
33. Franzen, D., Conway, R.S., Zhang, H., Sonnenblick, E.H., and Eng, C. 1988. Spatial heterogeneity of local blood flow and metabolite content in dog hearts. Am. J. Physiol. 254: H344-H353.PMID:3344825.
34. Fukuda, S., Kaga, S., Zhan, L., Bagchi, D., Das, D.K., Bertelli, A., and Maulik, N. 2006. Resveratrol ameliorates myocardial damage by inducing vascular endothelial growth factor -angiogen- esis and tyrosine kinase receptor Flk-1. Cell Biochem. Biophys. 44: 43-19. doi:10.1385/CBB:44:1:043. PMID:16456233.
35. Fukumura, D., Gohongi, T., Kadambi, A., Izumi, Y., Ang, J., Yun, C.O., et al. 2001. Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angio- genesis and vascular permeability. Proc. Natl. Acad. Sci. U.S.A. 98: 2604-2609. doi:10.1073/pnas.041359198. PMID:11226286.
36. Fulton, D., Gratton, J.P., McCabe, T.J., Fontana, J., Fujio, Y., Walsh, K., et al. 1999. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature, 399: 597-601. doi:10.1038/21218. PMID:10376602.
37. Gabrielsen, A., Lawler, P.R., Yongzhong, W., Steinbruchel, D., Blagoja, D., Paulsson-Berne, G., et al. 2007. Gene expression signals involved in ischemic injury, extracellular matrix composition and fibrosis defined by global mRNA profiling of the human left ventricular myocardium. J. Mol. Cell. Cardiol. 42: 870-883. doi:10.1016/j.yjmcc.2006.12.016. PMID:17343875.
38. Gao, L.R., Wang, Z.G., Tian, H.T., Zhu, Z.M., Fei, Y.X., Xu, H.T., et al. 2007. Autologous mononuclear bone marrow cell transplantation by intracoronary route for patients with ischemic heart disease: observation of 2-years follow-up. Zhonghua Yi Xue Za Zhi, 87: 685-689. PMID:17553306.
39. Goodchild, T., Pang, W., Tondato, F., Cui, J., Otsuka, Y., Frowein, S., et al. 2006. Safety of intramyocardial injection of autologous bone marrow cells to treat myocardial ischemia in pigs. Cardio- vasc. Revasc. Med. 7: 136-145. doi:10.1016/j.carrev.2006.04. 003. PMID:16945820.
40. Grover, G.J., and Garlid, K.D. 2000. ATP-Sensitive potassium channels: a review of their cardioprotective pharmacology. J. Mol. Cell. Cardiol. 32: 677-695. doi:10.1006/jmcc.2000.1111. PMID:10756123.
41. Grund, F., Treiman, C., and Ilebekk, A. 2006. How to discriminate between hibernating and stunned myocardium. J. Cardiovasc. Surg. (Torino), 47: 323-328. PMID:16760869.
42. Gunning, M.G., Kaprielian, R.R., Pepper, J., Pennell, D.J., Shep- pard, M.N., Severs, N.J., et al. 2002. The histology of viable and hibernating myocardium in relation to imaging characteristics. J. Am. Coll. Cardiol. 39: 428-435. doi:10.1016/S0735- 1097(01)01766-1. PMID:11823080.
43. Gyongyosi, M., Khorsand, A., Zamini, S., Sperker, W., Strehblow, C., Kastrup, J., et al. 2005. NOGA- guided analysis of regional myocardial perfusion abnormalities treated with intramyocardial injections of plasmid encoding vascular endothelial growth factor A-165 in patients with chronic myocardial ischemia: subana- lysis of the EUROINJECT-ONE multicenter double-blind randomized study. Circulation, 112: 157-165. doi:10.1161/circulationaha. 104.503631. PMID:15998683.
44. Haas, F., Jennen, L., Heinzmann, U., Augustin, N., Wottke, M., Schwaiger, M., and Lange, R. 2001. Ischemically compromised myocardium displays different time-courses of functional recovery: correlation with morphological alterations? Eur. J. Cardi- othorac. Surg. 20: 290-298. doi:10.1016/S1010-7940(01) 00781-3. PMID:11463546.
45. Han, W., Yu, Y., and Liu, X.Y. 2006. Local signals in stem cell- based bone marrow regeneration. Cell Res. 16: 189-195. doi:10.1038/sj.cr. 7310026. PMID:16474433.
46. Hasenfuss, G., Meyer, M., Schillinger, W., Preuss, M., Pieske, B., and Just, H. 1997. Calcium handling proteins in the failing human heart. Basic Res. Cardiol. 92: 87-93. doi:10.1007/ BF00794072. PMID:9202848.
47. Hedman, M., Hartikainen, J., Syvanne, M., Stjernvall, J., Hedman, A., Kivela, A., et al. 2003. Safety and feasibility of catheter- based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: phase II results of the Kuopio Angiogenesis Trial (KAT). Circulation, 107: 2677-2683. doi:10.1161/01.CIR.0000070540.80780. 92. PMID:12742981.
48. Hegazy, H., Refaei, A., Assedique, A., Alsaif, S., Taha, M., Refaei, M., et al. 2007. PET scan before CABG in diabetes. Br. J. Diabetes Vasc. Dis. 7: 32-37. doi:10.1177/14746514070070010601.
49. Hirata, A., Minamino, T., Asanuma, H., Fujita, M., Wakeno, M., Myoishi, M., et al. 2006. Erythropoietin enhances neovascularization of ischemic myocardium and improves left ventricular dysfunction after myocardial infarction in dogs. J. Am. Coll. Cardiol. 48: 176-184. doi:10.1016/j.jacc.2006.04. 008. PMID:16814664.
50. Horrigan, M.C., Malycky, J.L., Ellis, S.G., Topol, E.J., and Nico- lini, F.A. 1999. Reduction in myocardial infarct size by basic fibroblast growth factor following coronary occlusion in a canine model. Int. J. Cardiol. 68: S85-S91. doi:10.1016/S0167- 5273(98)00296-4. PMID:10328616.
51. House, S.L., Bolte, C., Zhou, M., Doetschman, T., Klevitsky, R., Newman, G., and Schultz Jel, J. 2003. Cardiac-specific overex- pression of fibroblast growth factor-2 protects against myocar- dial dysfunction and infarction in a murine model of low-flow ischemia. Circulation, 108: 3140-3148. doi:10.1161/01.CIR. 0000105723.91637.1C. PMID:14656920.
52. Hunt, I., and Ogunyiluka, T. 2006. Hibernating myocardium and coronary artery bypass surgery. Heart and Metabolism, 29: 1-7.
53. Isbell, D.C., and Kramer, C.M. 2006. Magnetic resonance for the assessment of myocardial viability. Curr. Opin. Cardiol. 21: 469-472. doi:10.1097/01.hco.0000240584.68720.ae. PMID:16900010.
54. Jiang, Z.S., Srisakuldee, W., Soulet, F., Bouche, G., and Kardami, E. 2004. Non- angiogenic FGF-2 protects the ischemic heart from injury, in presence or absence of reperfusion. Cardiovasc. Res. 62: 154-166. doi:10.1016/j.cardiores.2004.01.009. PMID:15023562.
55. Jonassen, A.K., Aasum, E., Riemersma, R.A., Mjos, O.D., and Lar- sen, T.S. 2000. Glucose-insulin-potassium reduces infarct size when administered during reperfusion. Cardiovasc. Drugs Ther. 14: 615-623. doi:10.1023/A:1007802630604. PMID:11300362.
56. Kalenikova, E.I., Gorodetskaya, E.A., Kolokolchikova, E.G., Sha- shurin, D.A., and Medvedev, O.S. 2007. Chronic administration of coenzyme Q10 limits postinfarct myocardial remodeling in rats. Biochemistry (Mosc.), 72: 332-338. doi:10.1134/S0006297907030121. PMID:17447888.
57. Kaprielian, R.R., Gunning, M., Dupont, E., Sheppard, M.N., Roth- ery, S.M., Underwood, R., et al. 1998. Downregulation of im- munodetectable connexin43 and decreased gap junction size in the pathogenesis of chronic hibernation in the human left ventricle. Circulation, 97: 651-660. PMID:9495300.
58. Kardami, E., Detillieux, K., Ma, X., Jiang, Z., Santiago, J.-J., Jimenez, S.K., and Cattini, P.A. 2007. Fibroblast growth factor-2 and cardioprotection. Heart Fail. Rev. 12: 267-277. doi:10.1007/ s10741-007-9027-0. PMID:17516168.
59. Kawai, T., Takahashi, T., Esaki, M., Ushikoshi, H., Nagano, S., Fu- jiwara, H., and Kosai, K. 2004. Efficient cardiomyogenic differentiation of embryonic stem cell by fibroblast growth factor 2 and bone morphogenic protein 2. Circ. J. 68: 691-702. doi:10.1253/circj.68.691. PMID:15226637.
60. Kelly, R.F., Sluiter, W., and McFalls, E.O. 2008. Hibernating myocardium: is the program to survive a pathway to failure? Circ. Res. 102: 3-5. doi:10.1161/CIRCRESAHA.107.168278. PMID: 18174469.
61. Kirk, E.S., and Honig, C.R. 1964. Nonuniform distribution of blood flow and gradients of oxygen tension within the heart. Am. J. Physiol. 207: 661-668. PMID:14220041.
62. Klein, H.M., Ghodsizad, A., Marktanner, R., Poll, L., Voelkel, T., Mohammad Hasani, M.R., et al. 2007. Intramyocardial implantation of CD133+ stem cells improved cardiac function without bypass surgery. Heart Surg. Forum, 10: E66-E69. doi:10.1532/HSF98.20061054. PMID:17162408.
63. Kloner, R.A., Bolli, R., Marban, E., Reinlib, L., and Braunwald, E. 1998. Medical and cellular implications of stunning, hibernation, and preconditioning: an NHLBI workshop. Circulation, 97:1848-1867. PMID:9603540.
64. Kovacic, J.C., Muller, D.W., and Graham, R.M. 2007. Actions and therapeutic potential of G-CSF and GM-CSF in cardiovascular disease. J. Mol. Cell. Cardiol. 42: 19-33. doi:10.1016/j.yjmcc. 2006.10.001. PMID:17109881.
65. Krause, K., Jaquet, K., Geidel, S., Schneider, C., Mandel, C., Schiele, W., et al. 2006. Cardioprotection after percutaneous in- tramyocardial injection of erythropoietin in hibernating myocardium. Z. Schrift fur Herz. 20: 53-59.
66. Kunapuli, S., Rosanio, S., and Schwarz, E.R. 2006. ''How do cardi- omyocytes die?'' Apoptosis and autophagic cell death in cardiac myocytes. J. Card. Fail. 12: 381-391. doi:10.1016/j.cardfail. 2006.02.002. PMID:16762802.
67. Kupatt, C., Hinkel, R., Vachenauer, R., Horstkotte, J., Raake, P., Sandner, T., et al. 2003. VEGF165 transfection decreases postis- chemic NF-kappa B-dependent myocardial reperfusion injury in vivo: role of eNOS phosphorylation. FASEB J. 17: 705-707. PMID:12586740.
68. Kupatt, C., Hinkel, R., von Brühl, M.L., Pohl, T., Horstkotte, J., Raake, P., et al. 2007. Endothelial nitric oxide synthase overex- pression provides a functionally relevant angiogenic switch in hibernating pig myocardium. J. Am. Coll. Cardiol. 49: 1575-1584. doi:10.1016/j.jacc.2006. 11.047. PMID:17418299.
69. Levine, B., and Klionsky, D.J. 2004. Development by self-digestion: molecular mechanisms and biological functions of autop- hagy. Dev. Cell, 6: 463-477. doi:10.1016/S1534-5807(04) 00099-1. PMID:15068787.
70. Lynch, P., Lee, T.-C., Fallavollita, J.A., Cantry, J.M., Jr., and Suzuki, G. 2007. Intracoronary administration of ADVFGF-5 (fi- broblast growth factor-5) ameliorates left ventricular dysfunction and prevents myocardial loss in swine with developing collaterals and ischemic cardiomyopathy. Circulation, 116: I71-I76. doi:10.1161/circulationaha.106.681866. PMID: 17846328.
71. MacLennan, D.H., and Kranias, E.G. 2003. Phospholamban: a crucial regulator of cardiac contractility. Nat. Rev. Mol. Cell Biol. 4: 566-577. doi:10.1038/nrm1151. PMID:12838339.
72. Maes, A., Flameng, W., Nuyts, J., Borgers, M., Shivalkar, B., Ausma, J., et al. 1994. Histological alterations in chronically hy- poperfused myocardium. Correlation with PET findings. Circulation, 90: 735-745. PMID:8044942.
73. Mahnken, A.H., Giinther, R.W., and Krombach, G. 2006. Contrast-enhanced MR and MSCT for the assessment of myocardial viability. Rofo. 178: 771-780. PMID:16862503.
74. Martinet, W., Knaapen, M.W., Kockx, M.M., and De Meyer, G.R. 2007. Autophagy in cardiovascular disease. Trends Mol. Med. 13: 482-491. doi:10.1016/j.molmed.2007.08.004. PMID:18029229.
75. Masri, C., and Chandrashekhar, Y. 2008. Apoptosis: a potentially reversible, meta-stable state of the heart. Heart Fail. Rev. 13: 175-179. doi:10.1007/s10741-007-9069-3. PMID:18214675.
76. Masuda, H., and Asahara, T. 2003. Post-natal endothelial progenitor cells for neovascularization in tissue regeneration. Cardio- vasc. Res. 58: 390-398. doi:10.1016/S0008-6363(02)00785-X. PMID:12757873.
77. May, D., Gilon, D., Djonov, V., Itin, A., Lazarus, A., Gordon, O., et al. 2008. Transgenic system for conditional induction and rescue of chronic myocardial hibernation provides insights into genomic programs of hibernation. Proc. Natl. Acad. Sci. U.S.A. 105: 282-287. doi:10.1073/pnas.0707778105. PMID:18162550.
78. Mazzadi, A.N., André -Fouët, X., Costes, N., Croisille, P., Revel, D., and Janier, M.F. 2006. Mechanisms leading to reversible mechanical dysfunction in severe CAD: alternatives to myocardial stunning. Am. J. Physiol. Heart Circ. Physiol. 291: H2570- H2582. doi:10.1152/ajpheart.01249.2005. PMID:16861690.
79. McFalls, E.O., Kelly, R.F., Hu, Q., Mansoor, A., Lee, J., Kus- kowski, M., et al. 2007. The energetic state within hibernating myocardium is normal during dobutamine despite inhibition of ATP- dependent potassium channel opening with glibenclamide. Am. J. Physiol. Heart Circ. Physiol. 293: H2945-H2951. doi:10.1152/ajpheart.00012.2007. PMID:17720774.
80. 2+- ATPase activity and dephosphorylated phospholamban contribute to contractile dysfunction in human hibernating myocardium. Mol. Cell. Biochem. 282: 53-63. doi:10.1007/s11010-006-1171-7. PMID:16317512.
81. Okruhlicová, Ľ., Tribulová, N., Miš ejková, M., Kučka, M., Štetka, R., Slezák, J., and Manoach, M. 2002. Gap junction remodelling is involved in the susceptibility of diabetic rats to hypokalemia- induced ventricular fibrillation. Acta Histochem. 104: 387-391. doi:10.1078/0065-1281-00675. PMID:12553708.
82. Page, B., Young, R., Iyer, V., Suzuki, G., Lis, M., Korotchkina, L., et al. 2008. Persistent regional down regulation in mitochondrial enzymes and upregulation of stress proteins in swine with chronic hibernating myocardium. Circ. Res. 102: 103-112. doi:10.1161/CIRCRESAHA.107.155895. PMID:17967786.
83. Papapetropoulos, A., García-Cardeña, G., Madri, J.A., and Sessa, W.C. 1997. Nitric oxide production contributes to the angio- genic properties of vascular endothelial growth factor in human endothelial cells. J. Clin. Invest. 100: 3131-3139. doi:10.1172/JCI119868. PMID:9399960.
84. Penumathsa, S.V., Thirunavukkarasu, M., Koneru, S., Juhasz, B., Zhan, L., Pant, R., et al. 2007. Statin and resveratrol in combination induces cardioprotection against myocardial infarction in hypercholesterolemic rat. J. Mol. Cell. Cardiol. 42: 508-516. doi:10.1016/j.yjmcc.2006.10.018. PMID:17188708.
85. Pfosser, A., Thalgott, M., Buttner, K., Brouet, A., Feron, O., Boek- stegers, P., and Kupatt, C. 2005. Liposomal Hsp90 cDNA induces neovascularization via nitric oxide in chronic ischemia. Cardiovasc. Res. 65: 728-736. doi:10.1016/j.cardiores.2004.10.019. PMID:15664400.
86. Piacentino, V., 3rd, Weber, C.R., Chen, X., Weisser- Thomas, J., Margulies, K.B., Bers, D.M., and Houser, S.R. 2003. Cellular basis of abnormal calcium transients of failing human ventricular myocytes. Circ. Res. 92: 651-658. doi:10.1161/01.RES. 0000062469.83985.9B. PMID:12600875.
87. Pizzuto, M.F., Valverde, A.M., Heavey, B.M., Banas, M.D., Michela- kis, N., Suzuki, G., et al. 2006. Brief sympathetic activation precedes the development of ventricular tachycardia and ventricular fibrillation in hibernating myocardium. J. Electrocardiol. 39: S140-S145. doi:10.1016/j.jelectrocard.2006.05.026.PMID:16919670.
88. Rahimtoola, S.H. 1985. A perspective on the three large multicenter randomized clinical trials of coronary bypass surgery for chronic stable angina. Circulation, 72: V123-V135. PMID:3905053.
89. Rahimtoola, S.H. 1989. The hibernating myocardium. Am. Heart J. 117: 211-221. doi:10.1016/0002-8703(89)90685-6. PMID:2783527.
90. Rajabi, M., Kassiotis, C., Razeghi, P., and Taegtmeyer, H. 2007. Return to the fetal gene program protects the stressed heart: a strong hypothesis. Heart Fail. Rev. 12: 331-343. doi:10.1007/ s10741-007-9034-1. PMID:17516164.
91. Rashed, E., and Depre, C. 2006. Cardiac cell survival and reversibility of myocardial ischemia. Arch. Mal. Coeur Vaiss. 99:1236-1243. PMID:18942527. Rudic, R.D., Shesely, E.G., Maeda, N., Smithies, O., Segal, S.S., and Sessa, W.C. 1998. Direct evidence for the importance of en- dothelium -derived nitric oxide in vascular remodeling. J. Clin. Invest. 101: 731-736. doi:10.1172/JCI1699. PMID:9466966.
92. Ruel, M., Wu, G.F., Khan, T.A., Voisine, P., Bianchi, C., Li, J., et al. 2003. Inhibition of the cardiac angiogenic response to surgical FGF-2 therapy in a Swine endothelial dysfunction model. Circulation, 108: II335-II340. doi:10.1161/01.cir.0000087903. 75204.ad. PMID:12970256.
93. Saffitz, J.E., Hames, K.Y., and Kanno, S. 2007. Remodeling of gap junctions in ischemic and nonischemic forms of heart disease. J. Membr. Biol. 218: 65-71. doi:10.1007/s00232-007-9031-2. PMID:17585361.
94. Saraste, A., Nekolla, S., and Schwaiger, M. 2008. Contrast-enhanced magnetic resonance imaging in the assessment of myo- cardial infarction and viability. J. Nucl. Cardiol. 15: 105-117. doi:10.1007/BF02976902. PMID:18242487.
95. Schinkel, A.F., Bax, J.J., Poldermans, D., Elhendy, A., Ferrari, R., and Rahimtoola, S.H. 2007. Hibernating myocardium: diagnosis and patient outcomes. Curr. Probl. Cardiol. 32: 375-410. doi:10.1016/j.cpcardiol.2007.04.001. PMID:17560992.
96. Schneider, C., Jaquet, K., Malisius, R., Geidel, S., Bahlmann, E., Boczor, S., et al. 2007. Attenuation of cardiac remodelling by endocardial injection of erythropoietin: ultrasonic strain-rate imaging in a model of hibernating myocardium. Eur. Heart J. 28: 499-509. doi:10.1093/eurheartj/ ehl439. PMID:17242014.
97. 2+-concentrations. J. Mol. Cell. Cardiol. 11: 45-55. doi:10.1016/0022-2828(79)90451-6. PMID:423255.
98. Shim, W.S.N., Li, W., Zhang, L., Li, S., Ong, H.C., Song, I.-C., et al. 2006. Angiopoietin-1 promotes functional neovascularization that relieves ischemia by improving regional reperfusion in a swine chronic myocardial ischemia model. J. Biomed. Sci. 13:579-591. doi:10.1007/s11373-006-9082- x. PMID:16547766.
99. Shivalkar, B., Maes, A., Borgers, M., Ausma, J., Scheys, I., Nuyts, J., et al. 1996. Only hibernating myocardium invariably shows early recovery after coronary revascularization. Circulation, 94:308-315. PMID:8759070.
100. Slezák, J. 1969. Ultrastructural changes in early stages of experimentally induced myocardial infarction. Folia Morphol. (Praha). 17: 228-245. PMID:5802134.
101. Slezak, J., and Klobusicka, M. 1969. To some questions of early changes of ischemic myocardium. Folia Morphol. (Praha), 17:165-170. PMID:5770334.
102. 2+ antagonist. In Recent advances in studies on cardiac structure and metabolism, pathophysiology and morphology of myocardial cell alteration. Edited by A. Fleck- enstein and G. Rona. University Park Press, Baltimore. pp. 75-84.
103. Slezák, J., Klobušická, M., and Styk, J. 1969. Some early changes of ischemic myocardium. Folia Morphol. (Praha). 17: 158-164. PMID:5770333.
104. Slezák, J., Geller, S.A., Litwak, R.S., and Smith, H., Jr. 1983. Long-term study of the ultrastructural changes of myocardium in patients undergoing cardiac surgery, with more than 10 years follow-up. Int. J. Cardiol. 4: 153-168. doi:10.1016/0167-5273(83)90129-8. PMID:6629529.
105. Slezák, J., Tribulová, N., Gabauer, I., Ziegelhoffer, A., Holec, V., and Slezák, J., Jr. 1987. Diminution of 'reperfusion injury' in reperfused ischemic myocardium by phenothiazines: a quantitative morphological study. Gen. Physiol. Biophys. 6:491-512. PMID:3428568.
106. Slezák, J., Tribulova, N., Schulze, W., Ziegelhoffer, A., Ravinger- ova, T., Okolicány, J., and Trégerová, V. 1989. Differences in transmural distribution of cardiomyocyte injury: Ca paradox versus postischemic reperfusion phenomenon. Biomed. Biochim. Acta, 48: S102-S107. PMID:2499317.
107. Slezak, J., Tribulova, N., Ravingerova, T., and Singal, P.K. 1992. Myocardial heterogeneity and regional variations in response to injury. Lab. Invest. 67: 322-330. PMID:1405491.
108. Slezák, J., Zlatoš, L., Randhawa, A., and Singal, P.K. 1994. Age- dependent differences in cardiac growth response to workload. In The cardiomyopathic heart. Edited by M. Nagano, N. Takeda, and N.S. Dhalla, Raven Press, New York. pp. 354-360.
109. Slezák, J., Tribulová, N., Ravingerová, T., Styk, J., Ziegelhoffer, A., Okruhlicova, L., and Slezáková, O. 1998. Heterogeneity in sensitivity of cardiac myocytes to ischemia as a substrate for arrhytmogenesis in ischemia and reperfusion. In Electrocardiology 1997. Edited by L. Bacharova, P.W. Macfarlane, World Scientific Publishing, Singapore, pp. 3-7.
110. Slezák, J., Styk, J., Slezáková, O., Wallukat, G., Karcewski, P., Schulze, W., and Buchwalow, I.B. 2002. Inducible nitric oxide synthase in cardiac adaptation to ischemia. In Myocardial Ischemia and Preconditioning. Edited by N. Dhalla et al. Kluwer Acad. Publ. Boston, pp. 127-138.
111. Slezák, J., Buchwalow, I.B., Schulze, W., Karczewski, P., Wallukat, G., Samoilova, V.E., et al. 2004. Cellular control of nitric oxide synthase expression and activity in rat cardiomyocytes. Antioxid. Redox Signal. 6: 345-352. doi:10.1089/152308604322899413. PMID:15025936.
112. Stein, P.D., Marzilli, M., Sabbah, H.N., and Lee, T. 1980. Systolic and diastolic pressure gradients within the left ventricular wall. Am. J. Physiol. 238: H625-H630. PMID:7377358.
113. Stromhaug, P.E., and Klionsky, D.J. 2001. Approaching the molecular mechanism of autophagy. Traffic, 2: 524-531. doi:10.1034/j.1600-0854. 2001.20802.x. PMID:11489210.
114. Thom, T., Haase, N., Rosamond, W., Howard, V.J., Rumsfeld, J., Manolio, T., et al. 2006. Heart disease and stroke statistics - 2006 update. A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation, 113: e85-e151. doi:10.1161/circulationaha.105. 171600. PMID:16407573.
115. Tribulová, N., Slezák, J., Ravingerová, T., Styk, J., and Gabauer, I. 1991. Vulnerability of specialized conductive tissue to ischemia and reperfusion related injury. Bratisl. Lek Listy (Tlacene Vyd), 92: 81-90.
116. Tribulová, N., Ravingerová, T., and Slezák, J. 1993. Reperfusion- induced arrhythmias in isolated rat heart: an index of cellular damage or viability of cardiomyocytes? J. Basic Clin. Physiol. Pharmacol. 4: 321-334. PMID:8664249.
117. Tribulová, N., Manoach, M., Varon, D., Okruhlicovám, Ľ., Styk, J., and Slezák, J. 1999. Alterations of intermyocyte coupling: possile determinant of atrial or ventricular fibrillations. In Electro- cardiology Singapore. Proceedings of the XXV International Congress on Electrocardiology. Edited by I. Préda. World Scientific Publishing, Singapore. pp. 169-173.
118. Tribulová, N., Novakova, S., Macsaliova, A., Sass, S., Thomas, S., Goetzfried, S., et al. 2002. Histochemical and ultrastructural characterisation of an arrhythmogenic substrate in ischemic pig heart. Acta Histochem. 104: 393-397. doi:10.1078/0065-1281- 00670. PMID:12553709.
119. Tribulová, N., Knezl, V., Okruhlicova, L., and Slezak, J. 2008. Myocardial gap junctions: targets for novel approaches in the prevention of life-threatening cardiac arrhythmias. Physiol. Res. 57: S1-S14. PMID:18373398.
120. Tse, H.F., and Lau, C.P. 2007. Therapeutic angiogenesis with bone marrow-derived stem cells. J. Cardiovasc. Pharmacol. Ther. 12: 89-97. doi:10.1177/1074248407303139. PMID:17562779.
121. Uemura, R., Xu, M., Ahmad, N., and Ashraf, M. 2006. Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circ. Res. 98: 1414-1421. doi:10.1161/01.RES.0000225952.61196. 39. PMID:16690882.
122. Vanoverschelde, J.L., Wijns, W., Depre, C., Essamrim, B., Heyn- drickx, G.R., Borgers, M., et al. 1993. Mechanisms of chronic regional postischemic dysfunction in humans. New insights from the study of noninfarcted collateral-dependent myocardium. Circulation, 87: 1513-1523. PMID:8491006.
123. von Degenfeld, G., Raake, P., Kupatt, C., Lebherz, C., Hinkel, R., Gildehaus, F.J., et al. 2003. Selective pressure-regulated retroin- fusion of fibroblast growth factor-2 into the coronary vein enhances regional myocardial blood flow and function in pigs with chronic myocardial ischemia. J. Am. Coll. Cardiol. 42: 1120-1128. doi:10.1016/S0735-1097(03)00915-X. PMID:13678941.
124. Wang, M., Tsai, B.M., Reiger, K.M., Brown, J.W., and Meldrum, D.R. 2006a. 17-beta-Estradiol decreases p38 MAPK-mediated myocardial inflammation and dysfunction following acute ischemia. J. Mol. Cell. Cardiol. 40: 205-212. doi:10.1016/j.yjmcc. 2005.06.019. PMID:16427650.
125. Wang, Y., Haider, H.K., Ahmad, N., Zhang, D., and Ashraf, M. 2006b. Evidence for ischemia induced host-derived bone marrow cell mobilization into cardiac allografts. J. Mol. Cell. Cardiol. 41: 478-487. doi:10.1016/j.yjmcc.2006.06.074. PMID:16926022.
126. Wang, L., Zhu, H.Y., Tian, J.M., Huang, S.D., Kong, L.S., and Lu, J.P. 2007. Magnetic resonance imaging in determination of myo- cardial ischemia and viability: comparison with positron emission tomography and single-photon emission computed tomography in a porcine model. Acta Radiol. 48: 500-507. doi:10.1080/02841850701280783. PMID:17520425.
127. Weber, K.T. 2000. Targeting pathological remodelling: concepts of cardioprotection and reparation. Circulation, 102: 1342-1345. PMID:10993849.
128. Wiggers, H., Nielsen, S.S., Holdgaard, P., Flø, C., Nørrelund, H., Halbirk, M., et al. 2006. Adaptation of nonrevascularized human hibernating and chronically stunned myocardium to long-term chronic myocardial ischemia. Am. J. Cardiol. 98: 1574-1580. doi:10.1016/j. amjcard.2006.07.035. PMID:17145213.
129. Wu, Y.-W., Tadamura, E., Yamamuro, M., Kanao, S., Marui, A., Tanabara, K., et al. 2007. Comparison of contrast-enhanced MRI with (18)F-FDG PET/201Tl SPECT in dysfunctional myocardium: relation to early functional outcome after surgical revascu- larization in chronic ischemic heart disease. J. Nucl. Med. 48: 1096-1103. doi:10.2967/jnumed.106.038596. PMID:17607039.
130. Yu, J., deMuinck, E.D., Zhuang, Z., Drinane, M., Kauser, K., Ru- banyi, G.M., et al. 2005. Endothelial nitric oxide synthase is critical for ischemic remodelling, mural cell recruitment, and blood flow reserve. Proc. Natl. Acad. Sci. U.S.A. 102: 10999-11004. doi:10.1073/pnas.0501444102. PMID:16043715.